Nucleophosmin delocalization in thyroid tumour cells (Q39603964)

13 September 2017

Nucleophosmin delocalization in thyroid tumour cells (English)

1 reference

13 September 2017

6

1 reference

13 September 2017

5

Milena Romanello

1 reference

13 September 2017

Annalisa Pianta

1

1 reference

13 September 2017

Cinzia Puppin

2

1 reference

13 September 2017

Nadia Passon

3

1 reference

13 September 2017

Alessandra Franzoni

4

1 reference

13 September 2017

Carla Di Loreto

7

1 reference

13 September 2017

Stefania Bulotta

8

1 reference

13 September 2017

Diego Russo

9

1 reference

13 September 2017

Giuseppe Damante

10

1 reference

13 September 2017

1 March 2011

1 reference

13 September 2017

6

1 reference

inferred from page(s)

published in

Endocrine Pathology

1 reference

13 September 2017

22

1 reference

13 September 2017

1

1 reference

13 September 2017

18-23

1 reference

https://scigraph.springernature.com/pub.10.1007/s12022-011-9147-x

13 September 2017

0 references

cites work

Major nucleolar proteins shuttle between nucleus and cytoplasm

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

21 January 2018

Nucleophosmin and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Nucleophosmin is overexpressed in thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Culture of hormone-dependent functional epithelial cells from rat thyroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Roles of histone acetyltransferases and deacetylases in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Iodide symporter gene expression in normal and transformed rat thyroid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Clinical implications of BRAF mutation in thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

New therapeutic advances in the management of progressive thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Epigenetic dysregulation in thyroid neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9147-X

Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23

21 January 2018

1 reference

12 December 2020

Functional proteomic analysis of melanoma progression

1 reference

12 December 2020

Induction of immune responses to ovarian tumor antigens by multiparity

1 reference

12 December 2020

Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism

1 reference

12 December 2020

Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.

1 reference

12 December 2020

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells

1 reference

12 December 2020

Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells

1 reference

12 December 2020

ApeI/Ref-I expression and cellular localization in human thyroid carcinoma cell lines

1 reference

12 December 2020

Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer

1 reference

12 December 2020

10.1007/S12022-011-9147-X

Identifiers

DOI

1 reference

13 September 2017

1 reference